WW International, Inc. offers worldwide weight management products and services. The company is headquartered in New York, New York.
| Revenue (TTM) | $665.49M |
| Gross Profit (TTM) | $472.64M |
| EBITDA | $96.85M |
| Operating Margin | 8.05% |
| Return on Equity | -30.70% |
| Return on Assets | -0.45% |
| Revenue/Share (TTM) | $66.60 |
| Book Value | $31.83 |
| Price-to-Book | 0.64 |
| Price-to-Sales (TTM) | 0.27 |
| EV/Revenue | 0.582 |
| EV/EBITDA | 0.34 |
| Quarterly Earnings Growth (YoY) | -91.00% |
| Quarterly Revenue Growth (YoY) | -14.20% |
| Shares Outstanding | $10.00M |
| Float | $6.92M |
| % Insiders | 8.23% |
| % Institutions | 86.03% |
Volatility is currently contracting
NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that the Company will be participating in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15th.
WW International, Inc. (WW) Q2 2026 Earnings Call Transcript
WW International NASDAQ: WW, the parent company of Weight Watchers, reported second-quarter 2026 revenue of $162.3 million, down from $189.2 million a year earlier, while highlighting growth in its clinical and higher-value behavioral membership tiers and reaffirming its full-year financial outlook.
Sam's Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam's Club members can save up to 50% on select Weight Watchers programs
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced a new summer collaboration with FlavCity, the fast-growing health and wellness brand known for bringing transparency, simplicity, and authenticity to everyday food choices. As Weight Watchers' official protein collaborator of the summer, FlavCity will help power the brand's focus on strength, nutrition, and community.
Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program. Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program.
Weight Watchers helps members achieve lasting weight loss through medication, personalized nutrition, and community support. As part of its collaboration with the American Heart Association, Weight Watchers is supporting enrollment and engagement in a nationwide study examining real-world health experiences and long-term health outcomes of people living with excess weight across weight management treatment pathways. Weight Watchers helps members achieve lasting weight loss through medication, personalized nutrition, and community support. As part of its collaboration with the American Heart Association, Weight Watchers is supporting enrollment and engagement in a nationwide study examining real-world health experiences and long-term health outcomes of people living with excess weight across weight management treatment pathways.
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss.
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) and its affiliated medical groups (“Weight Watchers”), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform, LillyDirect®. This news further reflects Weight Watchers' continued focus on expanding access to trusted, brand-name GLP-1 medications paired with comprehensive clinical and behavioral support, designed for real life.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WW and any ticker you trade — then tracks every position and per-strategy win rate.
